Tech mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say | The vaccines are tailor-made to target each patient’s unique cancer. By nitronewsworld@gmail.com Posted on January 23, 2026 Share Share Share Share Email Comments submitted by /u/ControlCAD [comments] Source link Related Items: Share Share Share Share Email Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.